Yahoo Web Search

Search results

  1. Jul 16, 2024 · The estimated Net Worth of Albert Bourla is at least $36.7 Million dollars as of 23 February 2024. Albert Bourla owns over 127,674 units of Pfizer stock worth over $13,179,248 and over the last 10 years he sold PFE stock worth over $5,557,386.

  2. Albert Bourla ( Greek: Άλμπερτ Μπουρλά; born October 21, 1961) is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions.

  3. Mar 4, 2022 · Net worth: $35.3 million. Albert Bourla, DVM, Ph.D. is the Chairman and CEO of Pfizer, a company that developed a COVID-19 vaccine and pill used to treat COVID-19 symptoms, although the oral...

  4. Mar 18, 2022 · Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year. Bourla’s total equity holdings, nearly 597,000 shares, are worth more than...

  5. Jul 16, 2024 · Albert Bourla has an estimated net worth of $14.1 Million. This is based on reported shares in PFIZER INC.

  6. Pfizer Chairman and CEO Albert Bourla summarizes company performance and achievements in 2023 and previews what’s to come as we celebrate 175 years of changing patients’ lives.

  7. Albert Bourla is Chairman/CEO at Pfizer Inc. See Albert Bourla's compensation, career history, education, & memberships.

  8. Jul 12, 2024 · The estimated Net Worth of Albert Bourla is at least $35.4 Million dollars as of 23 February 2024. Albert Bourla owns over 127,674 units of Pfizer stock worth over $11,925,966 and over the last 10 years he sold PFE stock worth over $5,557,386.

  9. Aug 3, 2023 · Albert Bourla's expertise and visionary approach have positioned him as a respected leader in the healthcare industry, shaping the future of medicine and patient care. Besides widespread recognition, Bourla has accumulated a stunning net worth of $36 Million.

  10. Nov 11, 2020 · Pfizer Chief Executive Officer Albert Bourla sold company shares worth $5.56 million, according to a regulatory filing that showed the sale was made on Monday, the same day the drugmaker...

  1. People also search for